| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Savior Lifetec Corporation (TWO: 4167)
4167 Technical Analysis
4
| As on 7th Nov 2025 4167 STOCK Price closed @ 17.90 and we RECOMMEND Sell for LONG-TERM with Stoploss of 21.30 & Strong Sell for SHORT-TERM with Stoploss of 23.38 we also expect STOCK to react on Following IMPORTANT LEVELS. |
4167STOCK Price
| Open | 17.30 | Change | Price | % |
| High | 18.15 | 1 Day | 0.70 | 4.07 |
| Low | 17.30 | 1 Week | 0.70 | 4.07 |
| Close | 17.90 | 1 Month | 0.05 | 0.28 |
| Volume | 2523286 | 1 Year | -4.90 | -21.49 |
| 52 Week High 26.20 | 52 Week Low 14.45 | ||||
TWO Taiwan Most Active Stocks
| 1815 | 75.00 | -6.25% |
| 8088 | 46.80 | 9.99% |
| 8096 | 53.50 | -3.08% |
| 5498 | 25.50 | -0.39% |
| 8111 | 66.50 | -1.63% |
| 6274 | 380.00 | -4.40% |
| 8054 | 127.50 | 2.41% |
| 5371 | 91.50 | -3.89% |
| 5289 | 456.00 | 0.22% |
| 6548 | 41.45 | -0.36% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
| 4167 Daily Charts |
4167 Intraday Charts |
Whats New @ Bazaartrend |
4167 Free Analysis |
|
|
4167 Important Levels Intraday
| RESISTANCE | 19.54 |
| RESISTANCE | 19.01 |
| RESISTANCE | 18.69 |
| RESISTANCE | 18.36 |
| SUPPORT | 17.44 |
| SUPPORT | 17.11 |
| SUPPORT | 16.79 |
| SUPPORT | 16.26 |
4167 Forecast November 2025
| 4th UP Forecast | 30.52 |
| 3rd UP Forecast | 26.47 |
| 2nd UP Forecast | 23.97 |
| 1st UP Forecast | 21.47 |
| 1st DOWN Forecast | 14.33 |
| 2nd DOWN Forecast | 11.83 |
| 3rd DOWN Forecast | 9.33 |
| 4th DOWN Forecast | 5.28 |
4167 Weekly Forecast
| 4th UP Forecast | 20.69 |
| 3rd UP Forecast | 19.80 |
| 2nd UP Forecast | 19.24 |
| 1st UP Forecast | 18.69 |
| 1st DOWN Forecast | 17.11 |
| 2nd DOWN Forecast | 16.56 |
| 3rd DOWN Forecast | 16.00 |
| 4th DOWN Forecast | 15.11 |
4167 Forecast2025
| 4th UP Forecast | 43.82 |
| 3rd UP Forecast | 35.51 |
| 2nd UP Forecast | 30.37 |
| 1st UP Forecast | 25.23 |
| 1st DOWN Forecast | 10.57 |
| 2nd DOWN Forecast | 5.43 |
| 3rd DOWN Forecast | 0.29 |
| 4th DOWN Forecast | -8.02 |
Savior Lifetec Corporation ( TWO Taiwan Symbol : 4167 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
4167 Business Profile
Savior Lifetec Corporation, a specialty injectable company, produces and supplies sterile APIs and finished dosage formulations. The company offers imipenem and cilastatin sodium, an antibacterial agent for intravenous infusion; and meropenem, a beta-lactamase resistant carbapenem antibiotic for parenteral administration. It also provides ertapenem, a form of carbapenem for use on gram-negative and gram-positive anaerobes and aerobic. The company's pipeline products include SLC-006 for prostate cancer endometriosis uterine leiomyoma; and sterile paliperidone palmitate API for the treatment of schizophrenia. Savior Lifetec Corporation was founded in 2004 and is headquartered in Miaoli County, Taiwan. Address: 29, Ke-Jhong Road, Miaoli, Taiwan, 35053
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service